EZH2 and hemoglobin measurement: Further studies are warranted to dissect the mechanistic underpinnings of EZH2-mediated oncogenesis in HB and to evaluate the therapeutic potential of EZH2 inhibition, particularly in combination with standard chemotherapeutics.